A New 3D Bioprinting Technique to Create Vascularized Human Tissue

A research team from the Jacobs School at the University of California, San Diego, are developing a new method of 3D bioprinting based on digital light processing (DLP). The project aims to create vascularized 3D-engineered tissues that, although produced in a lab, function as human-like living cells with biomaterial structures. The experimental study was published in Science Advances and explained in detail how the researchers successfully discovered one of the most promising types of 3D printing with biocompatible materials.

DLP 3D printing is one of the most widely used technologies in the medical sector. The implementation of this manufacturing method has great potential for biomedical applications. Some of these applications include drug development, organ transplantation, and regenerative and personalized medicine, among others. For some time now, this health sector branch has been limited by practical and technical aspects of additive manufacturing. These challenges include, for example, printing tissues with finely resolved structures and high cell densities. However, the Jacobs School team has opted for a different approach.

By reducing bio-ink density, light scattering is avoided (Credits: UC San Diego / David Baillot)

Creation of Vascularized Human Tissues

The nanoengineering team realized a 3D bioprinting system for vascularized human tissues. The patented technology is based on additive layering using cells and biopolymers to create biological structures and tissues. Generally, the higher the density of the bio-ink, the more light is scattered, which hinders the resolution of the print. To do this, the researchers obtained a biocompatible polymer for high-resolution DLP 3D printing. In this way, they reduced the light scattering effect tenfold and were able to print with high cell densities and high resolution, thanks to the contrast agent ‘iodixanol’ (a new ingredient in bio-ink).